[Advances in the application of regional citrate anticoagulation for continuous renal replacement therapy in patients with liver failure].
Zhonghua Gan Zang Bing Za Zhi
; 26(7): 549-552, 2018 Jul 20.
Article
em Zh
| MEDLINE
| ID: mdl-30317782
ABSTRACT
Currently, continuous renal replacement therapy (CRRT) is one of the most important means of organ support methods in critical care medicine. Anticoagulation is an essential part of the treatment process due to its prolonged duration. Patients with liver failure often have coagulation dysfunction and heparin anticoagulant can increase the risk of bleeding, but without heparin anticoagulant, coagulation can easily occur. In addition, an increased volumetric load, hemodynamic instability, nursing workload and other problems are major issues. Therefore, regional citrate anticoagulation (RCA) is the main anticoagulant method for CRRT therapy in patients with liver failure. This article reviews the mechanism, indications, advantages and disadvantages of using RCA to CRRT in hepatic failure.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Falência Hepática
/
Terapia de Substituição Renal
/
Ácido Cítrico
/
Injúria Renal Aguda
/
Anticoagulantes
Idioma:
Zh
Ano de publicação:
2018
Tipo de documento:
Article